119 related articles for article (PubMed ID: 9108818)
1. Dose-related thrombocytopenia and macrocytic anemia associated with valproate use in bipolar disorder.
Fawcett RG
J Clin Psychiatry; 1997 Mar; 58(3):125. PubMed ID: 9108818
[No Abstract] [Full Text] [Related]
2. Macrocytosis associated with divalproex treatment.
Tsivkin R; Saito E; Kafantaris V
J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):1011-4. PubMed ID: 16379522
[TBL] [Abstract][Full Text] [Related]
3. Haematological disturbances during long-term valproate therapy.
Brichard B; Vermylen C; Scheiff JM; Ninane J; Cornu G
Eur J Pediatr; 1994 May; 153(5):378-80. PubMed ID: 8033931
[TBL] [Abstract][Full Text] [Related]
4. Hematological effects of valproate in psychiatric patients: what are the risk factors?
Vasudev K; Keown P; Gibb I; McAllister-Williams RH
J Clin Psychopharmacol; 2010 Jun; 30(3):282-5. PubMed ID: 20473063
[TBL] [Abstract][Full Text] [Related]
5. Dose-dependent valproic acid thrombocytopenia in bipolar disorder.
Kaufman KR; Gerner R
Ann Clin Psychiatry; 1998 Mar; 10(1):35-7. PubMed ID: 9622048
[TBL] [Abstract][Full Text] [Related]
6. Myelodysplastic syndrome associated with chronic valproic acid therapy: a case report and review of the literature.
Allan RW
Hematology; 2007 Dec; 12(6):493-6. PubMed ID: 17852444
[TBL] [Abstract][Full Text] [Related]
7. Changes in red blood cells with valproate therapy.
Ozkara C; Dreifuss FE; Apperson Hansen C
Acta Neurol Scand; 1993 Sep; 88(3):210-2. PubMed ID: 8256557
[TBL] [Abstract][Full Text] [Related]
8. Thrombocytopenia during valproic acid treatment in young patients with new-onset bipolar disorder.
De Berardis D; Campanella D; Matera V; Gambi F; La Rovere R; Sepede G; Grimaldi MR; Pacilli AM; Salerno RM; Ferro FM
J Clin Psychopharmacol; 2003 Oct; 23(5):451-8. PubMed ID: 14520121
[TBL] [Abstract][Full Text] [Related]
9. Valproic Acid-related anticonvulsant hypersensitivity syndrome and subsequent olanzapine-related neutropenia and thrombocytopenia: a case report.
Lin YH; Chien YL
J Clin Psychopharmacol; 2012 Feb; 32(1):132-3. PubMed ID: 22217947
[No Abstract] [Full Text] [Related]
10. Severe hematologic toxicity of valproic acid. A report of four patients.
Ganick DJ; Sunder T; Finley JL
Am J Pediatr Hematol Oncol; 1990; 12(1):80-5. PubMed ID: 2106802
[TBL] [Abstract][Full Text] [Related]
11. A potential drug interaction between fluoxetine and valproic acid.
Sovner R; Davis JM
J Clin Psychopharmacol; 1991 Dec; 11(6):389. PubMed ID: 1770158
[No Abstract] [Full Text] [Related]
12. Sucralfate in bipolar patients with valproate intolerance.
Blum LD
J Clin Psychiatry; 1995 Sep; 56(9):432. PubMed ID: 7665544
[No Abstract] [Full Text] [Related]
13. The valproate serum level in maintenance therapy for bipolar disorder in Japan.
Machino A; Jitsuiki H; Okamoto Y; Izumitani S; Kimura Y; Suzuki K; Tanaka T; Inoue T; Koyama T; Wada K; Masaoka Y; Sasaki T; Yoshimura R; Nakamura J; Sumitan S; Ohmori T; Yamawaki S
Hiroshima J Med Sci; 2013 Mar; 62(1):7-12. PubMed ID: 23600328
[TBL] [Abstract][Full Text] [Related]
14. Treatment guidelines for valproate in bipolar and schizoaffective disorders.
McElroy SL; Keck PE
Can J Psychiatry; 1993 Apr; 38(3 Suppl 2):S62-6. PubMed ID: 8500081
[TBL] [Abstract][Full Text] [Related]
15. Valproate in bipolar disorder: the Canadian perspective.
Joffe RT
Can J Psychiatry; 1993 Apr; 38(3 Suppl 2):S46-50. PubMed ID: 8098990
[TBL] [Abstract][Full Text] [Related]
16. Clinical experience with valproic acid in 22 patients with refractory bipolar mood disorder.
Guscott R
Can J Psychiatry; 1992 Oct; 37(8):590. PubMed ID: 1423164
[No Abstract] [Full Text] [Related]
17. Reversible taste and smell dysfunction associated with sodium valproate and quetiapine in bipolar depression: a case report.
Alvarez P; Papaseit E; Pérez V; Bulbena A; Farré M
Actas Esp Psiquiatr; 2019 Jan; 47(1):33-6. PubMed ID: 30724329
[No Abstract] [Full Text] [Related]
18. Treatment of rapid cycling bipolar disorder with combination therapy of valproate and lithium.
Sharma V; Persad E; Mazmanian D; Karunaratne K
Can J Psychiatry; 1993 Mar; 38(2):137-9. PubMed ID: 8467440
[TBL] [Abstract][Full Text] [Related]
19. Concomitant use of valproate and carbamazepine in bipolar and schizoaffective disorders.
Tohen M; Castillo J; Pope HG; Herbstein J
J Clin Psychopharmacol; 1994 Feb; 14(1):67-70. PubMed ID: 8151006
[TBL] [Abstract][Full Text] [Related]
20. Successful reintroduction of valproic acid after the occurrence of pancytopenia.
Stewart JT
Am J Geriatr Pharmacother; 2011 Oct; 9(5):351-3. PubMed ID: 21962938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
